White label ELPA - ClinicalTrials.eu

Preventing Neuropathic Pain After Osteoporotic Vertebral Fracture with a 5% Lidocaine Patch in Adults

Recruiting

2 1 1 1
Investigated Drugs:
- Lidocaine
A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Recruiting

3 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
+4
Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Recruiting

3 1

+4
Study of Oral Misoprostol Combined with Osmotic Dilators for Labour Induction in Women with an Unprepared Cervix

Recruiting

3 1 1 1
Investigated Drugs:
- Misoprostol
A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Recruiting

4 1 1 1
Investigated Diseases:
- Age-related macular degeneration
Investigated Drugs:
- Fluorescein Sodium
- Aflibercept
+4
Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Recruiting

3 1 1 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Anifrolumab
Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Recruiting

3 1 1 1
Investigated Diseases:
- Central nervous system lymphoma
Investigated Drugs:
- Rituximab
- Temozolomide
+3
AUR200 for Patients with Generalized Myasthenia Gravis

Recruiting

1 1 1
Investigated Drugs:
- AUR200
- Sodium Chloride
Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Recruiting

2 1 1
Investigated Drugs:
- 2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione
+1
VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

Recruiting

3 1 1
Investigated Drugs:
- VMX-C001
+9

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies